SUBSCRIBE
SUBSCRIBE
News   Business

Elekta AB: Correction in the Annual Report 2012/13

August 30, 2013 | 
1 min read
free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Elekta (STO:EKTAB):

Contingent liabilities for the Group on page 86 and in note 29 on page 114 in the annual report 2012/13 is incorrect. The error is corrected in the attached version of the Annual Report. The correct figure should be according to the year-end report May-April 2012/13 and is SEK 178 M for April 30, 2013 and SEK 68 M for April 30, 2012.

Help employers find you! Check out all the jobs and post your resume.
Earnings Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
GSK restructure will hit home, impacting ‘limited’ UK roles
October 28, 2026
 · 
110 min read
 · 
BioSpace Editorial Staff
Balance vaccination and anti-vaccination. Vaccination or Anti-vaccination concept, vector illustration
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
October 28, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.
Earnings
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
October 28, 2026
 · 
1 min read
 · 
Annalee Armstrong